RDNT Key Statistics, Chart & Performance
The current stock price of RDNT is 70.95 USD. In the past month the price decreased by -10.71%. In the past year, price decreased by -0.78%.
RDNT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.7 | 101.72B | ||
| CI | THE CIGNA GROUP | 9.82 | 74.56B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 126.79 | 23.32B | ||
| LH | LABCORP HOLDINGS INC | 15.91 | 20.86B | ||
| DGX | QUEST DIAGNOSTICS INC | 17.81 | 19.33B | ||
| GH | GUARDANT HEALTH INC | N/A | 13.11B | ||
| DVA | DAVITA INC | 12.41 | 8.08B | ||
| HIMS | HIMS & HERS HEALTH INC | 61.87 | 7.61B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 37.65 | 6.93B | ||
| CHE | CHEMED CORP | 19.26 | 6.00B | ||
| OPCH | OPTION CARE HEALTH INC | 21.64 | 5.12B | ||
| BLLN | BILLIONTOONE INC CL A | N/A | 4.05B |
Related stock screener links
About RDNT
Company Profile
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 8,546 full-time employees. The company went IPO on 2001-12-12. The firm has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. The company is also a provider of AI-powered breast health solutions.
Company Info
RADNET INC
1510 Cotner Ave
Los Angeles CALIFORNIA 90025 US
CEO: Howard G. Berger
Employees: 8546
Phone: 13104787808
RADNET INC / RDNT FAQ
Can you describe the business of RADNET INC?
RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company is headquartered in Los Angeles, California and currently employs 8,546 full-time employees. The company went IPO on 2001-12-12. The firm has a network of 407 owned and/or operated outpatient imaging centers. Its Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Its services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. Its Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company provides radiology information technology and artificial intelligence (AI) solutions marketed under the DeepHealth brand and teleradiology professional services. The company is also a provider of AI-powered breast health solutions.
Can you provide the latest stock price for RADNET INC?
The current stock price of RDNT is 70.95 USD. The price decreased by -0.56% in the last trading session.
Does RDNT stock pay dividends?
RDNT does not pay a dividend.
How is the ChartMill rating for RADNET INC?
RDNT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is RADNET INC worth?
RADNET INC (RDNT) has a market capitalization of 5.47B USD. This makes RDNT a Mid Cap stock.
Can you provide the short interest for RDNT stock?
The outstanding short interest for RADNET INC (RDNT) is 12.08% of its float.
RDNT Technical Analysis
RDNT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RDNT. RDNT has a medium profitability rating, but doesn't score so well on its financial health evaluation.
RDNT Financial Highlights
Over the last trailing twelve months RDNT reported a non-GAAP Earnings per Share(EPS) of 0.38. The EPS decreased by -37.7% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.35% | ||
| ROE | -1.2% | ||
| Debt/Equity | 1.01 |
RDNT Forecast & Estimates
13 analysts have analysed RDNT and the average price target is 93.55 USD. This implies a price increase of 31.85% is expected in the next year compared to the current price of 70.95.
For the next year, analysts expect an EPS growth of -44.72% and a revenue growth 10.36% for RDNT